Dublin, May 19, 2017 -- Research and Markets has announced the addition of the "Needle-Free Drug Injection Systems - Global Strategic Business Report" report to their offering.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for Needle-Free Drug Injection Systems in US$ Million.
The report profiles 62 companies including many key and niche players such as
- AKRA Dermojet (France)
- Crossject SA (France)
- D'Antonio Consultants International, Inc. (USA)
- Medical International Technologies, Inc. (Canada)
- National Medical Products, Inc. (USA)
- PharmaJet (USA)
- Zogenix, Inc. (USA)
Key Topics Covered:
1. INDUSTRY OVERVIEW
- Needle-Free Drug Injection Systems: An Overview
- Needle-Free Drug Delivery Systems: An Overview
- Brief Glance of Needle-Free Drug Delivery Systems
- Advantages
- Disadvantages
- Needle-Free Drug Injection System: Market Dynamics
- Drivers and Barriers of Needle-free Drug Injection Systems Market
- Increasing Geriatric Population to Drive Market
- Improving Healthcare Expenditure to Foster Growth
- Increasing Incidence of Cancer Bodes Well for Needle-free Drug Injection Systems
- Global Cancer Prevalence Statistics
- Opportunity Indicators
- Expanding Therapeutic Applications to Generate Growth Opportunities
- Competitive Scenario
- Needle-free Jet Injections: Future Burning Bright
- Growth Factors
- Next Generation Needle-free Jet Technologies
- Advantageous to Different Stakeholders
- Applications
- Formulation Challenges
- Current Development Status
- The Road Ahead
- Innovations in Needle-Free Drug Injection System Technology
- Needle-free Arterial Non-Injectable Connector
- The Technology
- Limitations of Evidence
- Pulsed Micro Jets
2. FUTURE APPLICATIONS
- Inactivated Polio Vaccine
- Influenza Vaccine
- Measles-Mumps-Rubella Vaccine
- BCG Vaccine
- Yellow Fever Vaccine
- E. DTP-Hib-hep B Vaccine
- Rabies Vaccine
- Insulin Therapy
- Others
3. DRUG DELIVERY SYSTEMS - AN OVERVIEW
- Oral Vaccines
- Nasal Sprays, Suppositories and Eye and Nose Drops
- Inhalers
- Select Vaccine Inhalers in Development Stage (2016)
- Transdermal
- Injected Fine Mist or Powder
- Jet Injectors
- Iontophoretic Transdermal
- Patches
- Microneedles
- Implants
4. PRODUCT OVERVIEW
- Introduction
- Historical Background
- Mechanism
- Structure of Skin
- Epidermis
- Dermis
- Hypodermis
- Classification of Needle-Free Drug Injection Systems
- Based on Working
- Based on Load Type
- Based on Delivery Site
- Mode of Action of Needle-Free Drug Injection Systems
- Based on Mechanism
- Spring
- Laser
- Energy Propelled System
- Lorentz force
- Device Mechanism
- Gas Propelled/Air Forced
- Future Technologies
- Shock Waves
- Device Mechanism
- Based on Load Type
- Liquid
- Device Mechanism
- Powder
- Device Mechanism
- Projectile/Depot
- Based on Delivery Site
- Intradermal Injector
- Subcutaneous Injector
- Intramuscular Injector
- Material Used for Production
- Designing of Needle-free Injection Systems
- The Production Process
- Manufacturing the Pieces
- Assembling and Labeling
- Packaging
- Quality Control
- Safe Medical Devices
- Auto-Injectors and Pen Injector
- Benefits for Humans
- Greater Patient Acceptance and Compliance
- Enhanced Safety
- Improved Effectiveness
- Swift Injection Time
- Advantages of Using Needle-Free Injectors in Animals
- Disease Transmission Reduction
- Immunology Improvement
- Improvement in Beef Quality
- Employee Safety
- Needle-free Delivery of Liquids and Solids
- Select Needle-Free Drug Injection Systems Present in Market
5. RECENT INDUSTRY ACTIVITY
- PharmaJet® Adds Trivalent and Quadrivalent Influenza Vaccine to Injector System
- Eternity Healthcare's Lenis® Device Bags CE Certification
- PharmaJet® Inks Deal With Serum Institute to Launch Needle- free MMR Vaccine
- Inovio Pharmaceuticals Acquires BioJect Medical Technologies
- PharmaJet® Partners With Vaccibody for HPV Vaccine Development
- Zika Virus DNA Vaccine Clinical Trial Being Conducted With PharmaJet Needle-free Device
- PharmaJet Inks Partnership Agreement with Distributors for Marketing PharmaJet® Across the US
- Antares Pharma Bags FDA Approval for ZOMACTON and ZOMAJet
- Portal Instruments Raises US$25 million in Series B Financing
- West Pharmaceutical Services Bags 510(k) Clearance for Needle-stick Guards
- Crossject Develops Needle-Free Injection System
- The ZENEO Device
- FDA Grants Approval for Stratis Needle-Free Injection System
- Portal Instruments® Raises US$11 million from Sanofi
6. FOCUS ON SELECT PLAYERS
7. GLOBAL MARKET PERSPECTIVE
Total Companies Profiled: 62 (including Divisions/Subsidiaries 67)
- The United States (33)
- Canada (5)
- Japan (2)
- Europe (13)
- - France (3)
- - Germany (2)
- - The United Kingdom (4)
- - Rest of Europe (4)
- Asia-Pacific (Excluding Japan) (14)
For more information about this report visit http://www.researchandmarkets.com/research/l2mkpl/needlefree_drug
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Drug Delivery, Infusions and Injectables , Needles and Syringes


Micron to Expand Memory Chip Manufacturing Capacity in Singapore Amid Global Shortage
Meta Stock Surges After Q4 2025 Earnings Beat and Strong Q1 2026 Revenue Outlook Despite Higher Capex
Boeing Posts Fourth-Quarter Profit on Jeppesen Sale Despite Ongoing Unit Losses
Advantest Shares Hit Record High on Strong AI-Driven Earnings and Nvidia Demand
Tesla Loses Ground in Europe as BYD Accelerates EV Market Share in 2025
BYD and Exxon Mobil Strengthen Hybrid Technology Partnership
C3.ai in Merger Talks With Automation Anywhere as AI Software Industry Sees Consolidation
Sam Altman Criticizes ICE Enforcement as Corporate Leaders Call for De-Escalation
Tesla Q4 Earnings Beat Expectations as Company Accelerates Shift Toward AI and Robotics
Elon Musk Reportedly Eyes June 2026 SpaceX IPO Timed With Planetary Alignment and Birthday
LVMH Investors Watch Earnings Closely as Luxury Recovery Faces New Challenges
ASML’s EUV Monopoly Powers the Global AI Chip Boom
UK Politicians Call for Full Competition Review of Netflix’s Warner Bros Discovery Deal
Anthropic Raises 2026 Revenue Outlook by 20% but Delays Path to Profitability
First Abu Dhabi Bank Reports 22% Jump in Q4 Profit, Beats Market Expectations
The Maire - EuroChem Case: Three Lessons for Global Business
Volkswagen CEO Oliver Blume Faces Crucial Year as Investors Demand Turnaround Results 



